SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-043553
Filing Date
2012-08-08
Accepted
2012-08-08 14:01:34
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v320451_10q.htm 10-Q 508779
2 EXHIBIT 31.1 v320451_ex31-1.htm EX-31.1 12569
3 EXHIBIT 31.2 v320451_ex31-2.htm EX-31.2 12616
4 EXHIBIT 32.1 v320451_ex32-1.htm EX-32.1 4016
5 EXHIBIT 32.2 v320451_ex32-2.htm EX-32.2 3752
  Complete submission text file 0001144204-12-043553.txt   5219364

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT heb-20120630.xml EX-101.INS 800368
7 XBRL TAXONOMY EXTENSION SCHEMA heb-20120630.xsd EX-101.SCH 40673
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE heb-20120630_cal.xml EX-101.CAL 46617
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE heb-20120630_def.xml EX-101.DEF 140166
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE heb-20120630_lab.xml EX-101.LAB 320983
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE heb-20120630_pre.xml EX-101.PRE 275016
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13441 | Film No.: 121016299
SIC: 2836 Biological Products, (No Diagnostic Substances)